This valuable study investigates the role of HIF1a signaling in epicardial activation and neonatal heart regeneration in mice. Using a combination of genetic and pharmacological approaches, the ...
As Europe’s pharmaceutical sector strengthens its focus on specialty intermediates, terephthalic aldehyde has become indispensable for researchers and manufacturers pursuing synthetic versatility, ...
RAHWAY, N.J. - Merck (NYSE:MRK), a prominent player in the pharmaceutical industry with a market capitalization of $222.78 billion and an impressive gross profit margin of 77.41%, has initiated three ...
Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 5.7% in the afternoon session after the company announced positive results from its Phase 3 HYPERION trial for its drug, WINREVAIR™ ...
Merck & Co., Inc. (NYSE:MRK) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 30, Merck & Co., Inc. (NYSE:MRK) announced positive results from its Phase 3 HYPERION trial of ...
I believe that Merck (NYSE:MRK) is a good long-term pharmaceutical company to own and with that being said, it is because of several excellent moves it has made in the last few years. The first major ...
Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages of ...
Tulisokibart, an investigational anti-TL1A monoclonal antibody currently in Phase 3 trials for ulcerative colitis and Crohn’s disease, to be studied in hidradenitis suppurativa, radiographic axial ...
Merck Sharp & Dohme LLC has completed its acquisition of Verona Pharma plc (NASDAQ:VRNA), according to a statement filed with the Securities and Exchange Commission on Tuesday. The transaction was ...
Germany's Merck KGaA has been working hard to expand its healthcare product pipeline in recent months, and has now appointed industry veteran David Weinreich to oversee that process. Weinreich has ...
A top health official has suggested breaking up the combination measles, mumps and rubella (MMR) vaccine. In response to President Donald Trump’s recent statement warning about pregnant women's use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback